Immune reconstitution in the sigmoid colon after long-term HIV therapy

Mucosal Immunology

Volumn 1, Issue 5, 2008, Pages 382-388

  Sheth, P M ^a   Chege, D ^a   Shin, L Y Y ^a   Huibner, S ^a   Yue, F Y ^a   Loutfy, M ^b   Halpenny, R ^b   Persad, D ^b   Kovacs, C ^b   Chun, T W ^c   Kandel, G ^d   Ostrowski, M ^a   Kaul, R ^a,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b Canadian Immunodeficiency Research Collaborative   (Canada)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; GAG PROTEIN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ADULT; ARTICLE; BLOOD ANALYSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; COLON BIOPSY; CONTROLLED STUDY; CORRELATION ANALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOSTIMULATION; INTESTINE LYMPHATIC TISSUE; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MALE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; SIGMOID; T CELL DEPLETION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TREATMENT DURATION; TREATMENT OUTCOME; VIRUS LOAD; VIRUS REPLICATION;

EID: 50249123398     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2008.23     Document Type: Article

References (36)

1. UNAIDS/WHO AIDS epidemic update - December 2006. http://www.unaids.org/ en/HIV_data/epi2006/ (2006).
2. Douek, D. HIV disease progression: Immune activation, microbes, and a leaky gut. Top. HIV Med. 15, 114 (2007).
3. Lim, S.G. et al. Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin. Exp. Immunol. 92, 448 (1993).
4. Mowat, A.M. & Viney, J.L. The anatomical basis of intestinal immunity. Immunol. Rev. 156, 145 (1997).
5. Brenchley, J.M. et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200, 749 (2004).
6. Mehandru, S. et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200, 761 (2004).
7. Mattapallii, J.J. et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434, 1093 (2005).
8. Li, Q. et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434, 1148 (2005).
9. Veazey, R.S. et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280, 427 (1998).
10. Brenchley, J.M., Price, D.A. & Douek, D.C. HIV disease: Fallout from a mucosal catastrophe? Nat. Immunol. 7, 235 (2006).
11. Lederman, M.M. & Valdez, H. Immune restoration with antiretroviral therapies: Implications for clinical management. JAMA 284, 223 (2000).
12. Guadalupe, M. et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77, 11708 (2003).
13. Mehandru, S. et al. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoS Med. 3, e484 (2006).
14. Chun, T.W. et al. Persistence of HIV in Gut-associated lymphoid tissue despite long-term antiretroviral therapy. J. Infect. Dis. 197, 714 (2008).
15. Dandekar, S. Pathogenesis of HIV in the gastrointestinal tract. Curr. HIV/AIDS Rep. 4, 10 (2007).
16. Sankaran, S. et al. Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. Proc. Natl. Acad. Sci. USA 102 9860 (2005).
17. Brenchley, J.M. & Douek, D.C. HIV infection and the gastrointestinal immune system. Mucosal. Immunol. 1, 23 (2007).
18. Giorgi, J.V. et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179, 859 (1999).
19. Hazenberg, M.D. et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17, 1881 (2003).
20. Sodora, D.L. & Silvestri, G. Immune activation and AIDS pathogenesis. AIDS 22, 439 (2008).
21. Kinter, A.L. et al. CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific 1 cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200, 331 (2004).
22. Belkaid, Y. & Rouse, B.T. Natural regulatory T cells in infectious disease. Nat. immunol. 6, 353 (2005).
23. Jin, X. et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189, 991 (1999).
24. Kiepiela, P. et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13, 46 (2007).
25. Pontesilli, O. et al. Longitudinal analysis of human immunodeficiency virus type 1 -specific cytotoxic T lymphocyte responses: A predominant gag-specific response is associated with nonprogressive infection. J. Infect. Dis. 178, 1008 (1998).
26. Shacklett, B.L. et al. Trafficking of human immunodeficiency virus type 1-specific CD8(+) T cells to Gut-associated lymphoid tissue during chronic infection. J. Virol. 77, 5621 (2003),
27. Epple, H.J. et al. Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 108, 3072 (2006).
28. Haase, A.T. Perils at mucosal front lines for HIV and SIV and their hosts. Nat. Rev Immunol. 5, 783 (2005).
29. George, M.D. et al. High-throughput gene expression profiling indicates dysregulation of intestinal cell cycle mediators and growth factors during primary simian immunodeficiency virus infection. Virology 312, 84 (2003).
30. Guadalupe, M. et al. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J. Virol. 80, 8236 (2006).
31. Shacklett, B.L. et al. Characterization of HIV-1-specific cytotoxic T. lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects. Virology 270, 317 (2000).
32. Shacklett, B.L. et al. Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface. AIDS 14, 1911 (2000).
33. Kaul, R. et al. Quantitative ex vivo analysis of functional virus-specific CD8T lymphocytes in the blood and genital tract of HIV-infected women. AIDS 17, 1139 (2003).
34. Shetn, P.M. et al. HIV-specific CD8+ lymphocytes in semen are not associated with reduced HIV shedding. J. Immunol. 175, 4789 (2005). 35 Quayle, A.J. et al. Detection of HIV-1-specific CTLs in the semen of HIV infected individuals. J. Immunol. 161, 4406 (1998).
35. Kostense, S. et al. High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: Evidence for impaired CTL effector function. Eur. J. Immunol. 31, 677 (2001).
36. Chun, T.W. et al. Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines. J. Exp. Med. 188, 83 (1998).